NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma

Gliomas account for 75% of all primary malignant brain tumors in adults and are associated with high mortality. Mounting evidence has shown that NCAPG2 is differentially expressed in various cancers. However, the prognostic value and immune functions of NCAPG2 in low-grade glioma (LGG) remain unreso...

Full description

Bibliographic Details
Main Authors: Wenjun Ren, Shu Yang, Xi Chen, Jishu Guo, Heng Zhao, Ruihan Yang, Zhi Nie, Li Ding, Lei Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
low-grade glioma
NCAPG2
prognostic biomarker
immune infiltration
glioma stem cell
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.918606/full

Similar Items

Similar Items